In addition, as single‐cell‐based sequencing becomes more affordable, in‐depth characterization of the genomic architecture of AITL, especially the TET2 and DNMT3A relationship, will become possible. The gene discussed is TET2; the disease is angioimmunoblastic T-cell lymphoma.